These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8644842)

  • 21. The subcellular distribution of the p53 tumour suppressor, and organismal ageing.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2005; 10(3):439-53. PubMed ID: 16217555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular perspective: p53 tumor suppressor.
    Goodsell DS
    Oncologist; 1999; 4(2):138-9. PubMed ID: 10337384
    [No Abstract]   [Full Text] [Related]  

  • 23. p53 downstream target genes and tumor suppression: a classical view in evolution.
    Rozan LM; El-Deiry WS
    Cell Death Differ; 2007 Jan; 14(1):3-9. PubMed ID: 17068503
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular genetics of human pancreatic cancer].
    Villanueva A; Capellá G; Mangues R; Farré A; Lluís F
    Gastroenterol Hepatol; 1999 Nov; 22(9):444-50. PubMed ID: 10638042
    [No Abstract]   [Full Text] [Related]  

  • 25. [p53 as a molecular target for cancer therapy].
    Ishioka C; Osada M; Gamo M; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53.
    Ollmann M; Young LM; Di Como CJ; Karim F; Belvin M; Robertson S; Whittaker K; Demsky M; Fisher WW; Buchman A; Duyk G; Friedman L; Prives C; Kopczynski C
    Cell; 2000 Mar; 101(1):91-101. PubMed ID: 10778859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of p53 in reproduction, an unexpected function for a tumor suppressor.
    Hu W; Feng Z
    J Mol Cell Biol; 2019 Jul; 11(7):624-627. PubMed ID: 31310660
    [No Abstract]   [Full Text] [Related]  

  • 28. Falling out of the fold: tumorigenic mutations and p53.
    Erlanson DA; Verdine GL
    Chem Biol; 1994 Oct; 1(2):79-84. PubMed ID: 9383374
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutational spectra and immunohistochemical analyses of p53 in human cancers.
    Bennett WP; Hollstein MC; Hsu IC; Sidransky D; Lane DP; Vogelstein B; Harris CC
    Chest; 1992 Mar; 101(3 Suppl):19S-20S. PubMed ID: 1541189
    [No Abstract]   [Full Text] [Related]  

  • 30. p53: tumor suppression through control of the cell cycle.
    Kern SE
    Gastroenterology; 1994 Jun; 106(6):1708-11. PubMed ID: 8194721
    [No Abstract]   [Full Text] [Related]  

  • 31. Promotability and tissue specificity of hereditary cancer genes: do hereditary cancer patients have a reduced requirement for tumor promotion because all their somatic cells are heterozygous at the predisposing locus?
    Paraskeva C; Williams AC
    Mol Carcinog; 1992; 5(1):4-8. PubMed ID: 1543540
    [No Abstract]   [Full Text] [Related]  

  • 32. The many faces of p53: something for everyone.
    Levine AJ
    J Mol Cell Biol; 2019 Jul; 11(7):524-530. PubMed ID: 30925588
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecule of the year.
    Koshland DE
    Science; 1993 Dec; 262(5142):1953. PubMed ID: 8266084
    [No Abstract]   [Full Text] [Related]  

  • 34. UICC Study Group on Basic and Clinical Cancer Research: genotypes and phenotypes of tumor suppressors. Meeting held at Woods Hole, MA, October 1-4, 1992.
    Levine AJ; Burger MM
    Int J Cancer; 1993 Apr; 53(6):883-5. PubMed ID: 8473046
    [No Abstract]   [Full Text] [Related]  

  • 35. To study the effect of curcumin on the growth properties of circulating endothelial progenitor cells.
    Vyas D; Gupt S; Dixit V; Anita K; Kaur S
    In Vitro Cell Dev Biol Anim; 2015 May; 51(5):488-94. PubMed ID: 25583641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA damage in human pterygium: one-shot multiple targets.
    Cimpean AM; Sava MP; Raica M
    Mol Vis; 2013; 19():348-56. PubMed ID: 23401662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation metabolomics and its potential in biodosimetry.
    Coy SL; Cheema AK; Tyburski JB; Laiakis EC; Collins SP; Fornace A
    Int J Radiat Biol; 2011 Aug; 87(8):802-23. PubMed ID: 21692691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Two faces" of Tumor Suppressor p53-revisited.
    Smith ML; Kumar MA
    Mol Cell Pharmacol; 2010 Jan; 2(3):117-119. PubMed ID: 20686673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response.
    Lyakhovich A; Shekhar MP
    Mol Cell Biol; 2003 Apr; 23(7):2463-75. PubMed ID: 12640129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers.
    Marsella JM; Liu BL; Vaslet CA; Kane AB
    Environ Health Perspect; 1997 Sep; 105 Suppl 5(Suppl 5):1069-72. PubMed ID: 9400702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.